• Profile
Close

Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with APRT deficiency: A clinical trial

European Journal of Internal Medicine Dec 19, 2017

Edvardsson VO, et al. - A comparative scrutiny was carried out of the effect of xanthine oxidoreductase inhibitors allopurinol and febuxostat on urinary 2,8-dihydroxyadenine (DHA) excretion in adenine phosphoribosyltransferase (APRT) deficiency patients. The results disclosed a decrease in the urinary DHA excretion with conventional doses of both allopurinol and febuxostat. Nevertheless, febuxostat was markedly more efficacious than allopurinol in reducing DHA excretion in the prescribed doses. This, in turn, possibly depicted improved outcomes of patients with APRT deficiency.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay